Disable all preview features

Health : Medical Research (Grantmaking/Grants Payable)

ABC² (Accelerate Brain Cancer Cure)

Brain cancer breakthroughs don't follow conventional wisdom. Neither do we.

two stars

73.69

1717 Rhode Island Avenue, NW Suite 700
Washington, DC 20036
tel: (202) 419-3140   Web Site
EIN: 52-2320756

Board Leadership
Steve Case
Chair

CEO
Max Wallace
Chief Executive Officer

 
 
  Score
(out of 100)
Rating
Overall Score & Rating 73.69 two stars
  Financial 63.67 one star
  Accountability & Transparency 92.00 four stars
This rating was published 05/01/2020 and includes data from FY2018, the most recent 990 received at that time.

ABC² (Accelerate Brain Cancer Cure) invests in research aimed at finding the fastest possible route to a cure. Brain cancer breakthroughs don't follow conventional wisdom. Neither do we. ABC² partners with scientists, physicians and drug companies to push the limits of science and technology. We have awarded more than 100 grants totaling over $21 million to world-renowned researchers and physician-scientists from 54 institutions. Since our founding in 2001, we have helped drive 30 treatments into the clinic for patients - an unmatched record for a nonprofit in our field.

ABC² (Accelerate Brain Cancer Cure) invests in research aimed at finding the fastest possible route to a cure. Brain cancer breakthroughs don't follow conventional wisdom. Neither do we. ABC² partners with scientists, physicians and drug companies to push the limits of science and technology. We have awarded more than 100 grants totaling over $21 million to world-renowned researchers and physician-scientists from 54 institutions. Since our founding in 2001, we have helped drive 30 treatments into the clinic for patients - an unmatched record for a nonprofit in our field.

Impact Information

data icon Looking for Impact Information?

Charity Navigator is collaborating with GuideStar, GlobalGiving, Classy, and ImpactMatters to display impact-related information on our rated profile pages. Each partner collects this data directly from nonprofits and provides updates to Charity Navigator when available.

If you are interested in seeing this charity provide its impact information, please click below. This will indicate your interest and encourage the nonprofit to share data with partners that are currently collecting information.

Financial

one star

63.67

Accountability & Transparency

four stars

92.00

This rating was published 05/01/2020 and includes data from FY2018, the most recent 990 received at that time.
Overall Rating Chart
  Program Expenses
(Percent of the charity's total expenses spent on the programs
and services it delivers)
50.0%
  Administrative Expenses 17.1%
  Fundraising Expenses 32.7%
  Fundraising Efficiency $0.34
  Working Capital Ratio (years) 1.42
  Program Expenses Growth 1.7%
  Liabilities to Assets 9.0%
All data for Financial Performance Metrics calculations was provided by ABC² (Accelerate Brain Cancer Cure) on recent 990s filed with the IRS.
All data for Financial Performance Metrics calculations was provided by ABC² (Accelerate Brain Cancer Cure) on recent 990s filed with the IRS.

Highly Rated

Charity Name & State Overall Score Overall Rating
ABC² (Accelerate Brain Cancer Cure) (DC) 73.69 two stars
Chordoma Foundation (NC) 91.09 four stars
Damon Runyon Cancer Research Foundation (NY) 94.89 four stars
Friends of Cancer Research (DC) 87.09 three stars
Dr. Susan Love Foundation for Breast Cancer Research (CA) 91.90 four stars

Compare These Charities (Highly Rated)

REVENUE  
Contributions  
   Contributions, Gifts & Grants $804,931
   Federated Campaigns $0
   Membership Dues $0
   Fundraising Events $1,107,743
   Related Organizations $0
   Government Grants $0
Total Contributions $1,912,674
   Program Service Revenue $0
Total Primary Revenue $1,912,674
   Other Revenue $2,681
TOTAL REVENUE $1,915,355
   
EXPENSES  
   Program Expenses $669,406
   Administrative Expenses $340,607
   Fundraising Expenses $574,271
TOTAL FUNCTIONAL EXPENSES $1,584,284
   
Payments to Affiliates $0
Excess (or Deficit) for the year $331,071
   
Net Assets $2,819,388

Program names and associated costs are listed for the top programs as reported on the charity's most recently filed Form 990. The top programs displayed will include the largest three programs, or those programs covering at least 60% of the charity's total expenses, whichever comes first.

Program Name Amount Spent % of Program Expenses
Funding Translational Research $669,406 100.0%

Ratings History

Form 990 FYE Date Published Overall Score Overall Rating
CN 2.1
2018-12 05/01/2020 73.69 two stars
2017-12 10/01/2019 79.38 two stars
2016-12 12/01/2018 79.97 two stars
2015-12 06/01/2017 78.51 two stars
2014-12 02/01/2017 73.48 two stars
2014-12 07/01/2016 73.33 two stars
2014-12 06/01/2016 72.36 two stars
 
CN 2.0
2014-12 04/01/2016 71.16 two stars
2013-12 07/01/2015 74.91 two stars
2012-12 05/01/2014 83.92 three stars
2011-12 06/01/2013 80.37 three stars
2010-12 06/01/2012 82.22 three stars

The data displayed on this tab is provided by the IRS in the form of Publication 78 and the Business Master File (BMF).

EIN 52-2320756
Name in IRS Master File ACCELERATE BRAIN CANCER CURE INC
NTEE Code H12
NTEE Classification Fund Raising and/or Fund Distribution
NTEE Type Medical Research
Classification Charitable Organization
Subsection 501(c)(3)  (View the list of codes)
Activities
Foundation Status Organization which receives a substantial part of its support from a governmental unit or the general public   170(b)(1)(A)(vi)
Deductibility Contributions are deductible
Affiliation Independent - the organization is an independent organization or an independent auxiliary (i.e., not affiliated with a National, Regional, or Geographic grouping of organizations).
Group Name [Not Applicable]
Ruling Date July, 2002
Filing Requirement 990 (all other) or 990EZ return
Fiscal Year End December
IRS Forms 990
(provided courtesy of Foundation Center)
(Log In or Register Now to View Forms 990!)
  • December, 2017
  • December, 2016
  • December, 2015
  • December, 2014
  • December, 2013
Compensation % of Expenses Paid to Title
$305,599 19.28% Max Wallace President, CEO

Highly Rated

Charity Name & State Overall Score Overall Rating
ABC² (Accelerate Brain Cancer Cure) (DC) 73.69 two stars
Breast Cancer Research Foundation (NY) 89.56 three stars
Cancer Research Institute (NY) 94.12 four stars
The Multiple Myeloma Research Foundation (CT) 96.25 four stars
International Waldenstrom's Macroglobulinemia Foundation (FL) 95.59 four stars

Compare These Charities (Highly Rated)

This charity has an official representative registered with Charity Navigator.

Charity Contact Info

ABC² (Accelerate Brain Cancer Cure)
1717 Rhode Island Avenue, NW
Suite 700
Washington, DC 20036
tel: (202) 419-3140
EIN: 52-2320756

Visit Web Site

Board Leadership

Steve Case
Chair

CEO

Max Wallace
Chief Executive Officer

Join Our Mailing List

Join over 400,000 other informed givers and get updates on charity ratings, new features, hot topics, and tips for donating.